Fenglong Yu

In vivo Radioiodide Imaging and Treatment of Pancreatic Cancer Xenografts after MUC1 Promoter-Driven Expression of the Human Sodium-Iodide Symporter

Ru-fu Chen, Zhi H. Li, Qiu-hui Pan, 2007, Pancreatology.

IDO1 Inhibition Synergizes with Radiation and PD-1 Blockade to Durably Increase Survival Against Advanced Glioblastoma

C. James, R. Stupp, D. Scholtens, 2018, Clinical Cancer Research.

Abstract 1651: BGB-290, a novel PARP inhibitor with unique brain penetration ability, demonstrated strong synergism with temozolomide in subcutaneous and intracranial xenograft models

B. Jiang, Zhe Shi, L. Luo, 2015 .

Pamiparib is a potent and selective PARP inhibitor with unique potential for the treatment of brain tumor

X. Liu, Xiaomin Song, Zhirong Shen, 2020, Neoplasia.

Discovery of Pamiparib (BGB-290), a Potent and Selective Poly (ADP-ribose) Polymerase (PARP) Inhibitor in Clinical Development.

Zhiwei Wang, X. Liu, L. Luo, 2020, Journal of medicinal chemistry.

Abstract 1653: BGB-290: A highly potent and specific PARP1/2 inhibitor potentiates anti-tumor activity of chemotherapeutics in patient biopsy derived SCLC models

B. Jiang, Zhe Shi, Jun Zhao, 2015 .

Discovery of Pamiparib (BGB-290), a Potent and Selective Poly (ADP-ribose) Polymerase (PARP) Inhibitor in Clinical Development.

Zhiwei Wang, X. Liu, L. Luo, 2020, Journal of medicinal chemistry.